Novel variants provide differential stabilisation of human equilibrative nucleoside transporter 1 states
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Molecular Biosciences"
DOI: 10.3389/fmolb.2022.970391
Abstract: Human equilibrative nucleoside transporters represent a major pharmaceutical target for cardiac, cancer and viral therapies. Understanding the molecular basis for transport is crucial for the development of improved therapeutics through structure-based drug design. ENTs have… read more here.
Keywords: equilibrative nucleoside; novel variants; human equilibrative; nucleoside transporter ... See more keywords